2d
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
The past couple of years have been volatile for Vertex Pharmaceuticals (VRTX-2.07%). Between clinical setbacks and worse-than ...
Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different ...
Vertex Pharmaceuticals' revenue from its cystic fibrosis franchise grew 10% quarter-on-quarter. Click here to see why VRTX ...
STATEN ISLAND, N.Y., Aug. 14, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics ...
Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean ...
The number of patients experiencing moderate to severe odynophagia (pain swallowing) in the cohorts analyzed (Cohorts 7-9) was reduced from 62% ...
A label can end a debate before the evidence is heard. From Nazi propaganda to "quack" science, see how labels are weaponized ...
A medication used to treat hypothyroidism, or an underperforming thyroid, is being recalled because it may not have been made to be as strong as intended. Major Pharmaceuticals is recalling several ...
Paavo Sillanpää of UPM Adhesive Materials explains why pharmaceutical-grade labels are essential for demanding labeling applications and how to avoid label defects and brand risks. With the continued ...
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards established in the Twombly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results